LCM
ALT icon

Landscape Capital Management’s Altimmune ALT Stock Holding History

Landscape Capital Management’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-30,066
Closed -$127K – 568
2023
Q1 		$127K Buy
30,066
+1,091
+4% +$13K 0.02% 518
2022
Q4 		$477K Buy
+28,975
New +$325K 0.07% 273

Other funds holding ALT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Landscape Capital Management's ALT Position: Q2 2023 in Review

Landscape Capital Management sold out of Altimmune (ALT) in Q2 2023, closing a stake of 30,066 shares — an estimated $127K sold.

Landscape Capital Management first reported a position in ALT in Q4 2022 and held it in 2 quarters. The position peaked at $477K in Q4 2022. 120 funds tracked by Wall St. Rank hold ALT as of Q2 2023.

  • Landscape Capital Management reported no remaining Altimmune position as of Q2 2023 after selling out during the quarter.
  • Landscape Capital Management sold 30,066 Altimmune shares in Q2 2023, an estimated $127K.
  • Landscape Capital Management first reported a position in Altimmune in Q4 2022 and held it in 2 quarters.
  • Landscape Capital Management's Altimmune position peaked at $477K in Q4 2022.
  • 120 funds tracked by Wall St. Rank held Altimmune as of Q2 2023.

Based on Landscape Capital Management's 13F filing for Q2 2023, filed 11 Aug 2023.